Skip to content
Clinical Trial Events
LSX Investival Showcase London 2026

Panel Medtech Showcase Stage track

Capital Allocation in Medtech: What VCs Are Backing & Why

Mon, Nov 16, 2026 · 10:30–11:00 AM GMT Old Billingsgate

About this session

Medtech investment trends are shifting as VCs reassess risk, return timelines, and market opportunities across therapeutic areas and technology platforms. Some sectors are seeing increased capital flow while others face funding headwinds. This panel features active medtech investors who will share where they're deploying capital today, what clinical and commercial characteristics drive their investment decisions, and which innovation areas they believe offer the strongest risk-adjusted returns.

Speakers

  • Jan Engels

    Senior Investment Manager · High-Tech Gründerfonds

    Moderator

  • Robert Hornby

    Investment Director · Mercia Ventures

    Panelist

  • Thom Rasche

    Managing Partner · Earlybird

    Panelist

  • Caroline Gaynor

    Partner · Lightstone Ventures

    Panelist